The program explores the role of long-acting injectable antipsychotic medications in treating patients with schizophrenia, schizoaffective disorder and bipolar disorder
CRANBURY, N.J.–(BUSINESS WIRE)–Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, in partnership with Asembia, a leading provider of solutions and services for the specialty pharmaceutical channel, will host a live virtual symposium titled, “The Expanding Role of the Pharmacist: Proper Use and Administration of Long-Acting Injectable Antipsychotic Medications,” on Wednesday, Aug. 21 from 7:00 to 8:30 PM (EST).
The symposium will feature Karleen Melody, PharmD, BCACP, associate professor of clinical pharmacy, Philadelphia College of Pharmacy at the University of the Sciences and Lindsey N. Miller, PharmD, BCPP, associate professor, department of pharmacy practice, Lipscomb University College of Pharmacy, clinical pharmacist, Vanderbilt Psychiatric Hospital.
“We are proud to present this live virtual symposium in partnership with Asembia on how pharmacists can properly use LAIAs to overcome barriers to adherence in certain mental disorders,” said Jim Palatine, RPh, MBA, president of PTCE. “The LAIAs provide an option for long-term disease control and eliminate the need for daily oral medication.”
Designed for retail, managed care and specialty pharmacists, this live symposium will discuss long-acting injectable antipsychotic medications (LAIAs) and their place in therapy for those living with schizophrenia, schizoaffective disorder and bipolar disorder. Through this live virtual symposium, pharmacists will compare all available LAIA formulations and be able to identify available opportunities to administer LAIAs in their practice. This symposium will also feature device demonstration videos for the various LAIA agents.
“This unique symposium will help prepare pharmacists to provide the best possible care to patients undergoing these complex therapies,” said Robert Irene, RPh, president of Asembia. “As a leader in specialty pharmacy, Asembia is proud to collaborate with PTCE for this educational opportunity, an example of one of the many important services we provide to the industry.”
The activity is accredited by the Accreditation Council for Pharmacy Education and approved for 1.5 contact hours and is supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.
To learn more and to register, click here.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE’s print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team. PTCE is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.
Asembia works with member pharmacies, manufacturers, prescribers, payers, and other industry stakeholders to develop solutions for the high-touch specialty pharmaceutical service model. Through collaborative programs, contracting initiatives, patient support HUB services and innovative technology platforms, Asembia is committed to providing solutions that impact the patient journey. Asembia is also founder and host of the nation’s leading healthcare conference focused on increasing the quality of patient care through specialty pharmaceutical services. For more information, visit www.asembia.com.
Alexandra Ventura, 609-716-7777, ext. 121
John Patricolo, 609-325-4630